ZeClinics is a contract research organization (CRO) specialized in zebrafish, based in Barcelona, Spain. They offer a diverse array of highly customizable preclinical services utilizing zebrafish, along with a range of in vivo safety and efficacy assessments. Leveraging expertise in CRISPR technology, they develop genetic models that mimic human disease.

Their mission is to assist pharmaceutical, agrochemical, food, and cosmetic companies, as well as academic research institutions, in accelerating drug and target discovery, and enhancing the value of their early-stage R&D process using zebrafish.

Driven by their commitment to advancing research and delivering benefits to patients, they integrate expertise in zebrafish biology with lab automation and artificial intelligence. ZeClinics optimizes time and cost requirements in early compound development, revolutionizing preclinical research for faster market entry.